Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chipotle Mexican Grill, Inc. (CMG) vs Humana Inc (HUM) Price & Performance

Chipotle Mexican Grill, Inc.Trade
Humana IncTrade

Price performance (Past 24H)

Key statistics

Chipotle Mexican Grill, Inc. vs Humana Inc — how do they compare? Chipotle Mexican Grill, Inc. trades at $36.04 (market cap $46.73B), while Humana Inc trades at $402.89 (market cap $48.84B). The key difference: Chipotle Mexican Grill, Inc. and Humana Inc are close in size by market cap, and Humana Inc pays a 0.87% dividend while Chipotle Mexican Grill, Inc. pays none. Which is the better fit depends on your goals.

CMGHUM
Market Cap
$46.73B$48.84B
Sector
Consumer CyclicalHealth
52-Week High
$53.95$409.42
52-Week Low
$28.17$163.67
Enterprise Value
$51.11B$57.88B
Dividend Yield
0.87%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Chipotle Mexican Grill, Inc.

Chipotle Mexican Grill (CMG) trades at $36.63, up 3.91% with strong technical and fundamental momentum. The stock shows bullish technical signals with support at $36 and resistance at $37-38. Recent earnings beats and international expansion into Mexico highlight growth potential, though valuation remains elevated with a P/E of 33.61. Analyst consensus is strongly bullish with 70% buy ratings and a $40.43 price target.

CMG offers growth exposure through international expansion and operational excellence, but faces risks from premium valuation and margin pressures. Revenue growth has slowed to 5.3% in 2025 from 15.1% in 2023, while net margins declined to 12.87%. The stock's premium multiple requires sustained execution to justify current levels amid competitive and inflationary pressures.

Humana Inc

Humana (HUM) trades at $406.00, up 3.51% with strong technical bullish signals and recent earnings beats. The stock shows robust revenue growth reaching $129.66 billion in 2025, though net margins have compressed to 0.82%. Analyst sentiment is mixed with 32% buy ratings but a consensus price target of $354.33 below current levels. Recent developments include Medicare Advantage margin targets and Illinois Medicaid contract wins.

The outlook remains cautious despite operational strengths. While CenterWell expansion and margin recovery plans offer upside, current valuation at 43x P/E appears stretched relative to earnings growth. Key risks include regulatory scrutiny, healthcare utilization costs, and ongoing insider trading investigations that could pressure shareholder returns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Chipotle Mexican Grill, Inc.

Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.

Read more on CMG

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM